MarketBeat
908 Devices Calls “Inflection Point,” Targets 15%-20% 2026 Growth on Field Detection Demand
📈
AI Sentiment
Highly Positive
9/10
- Home
- MASS
MASS
908 Devices Inc.
as of 03-23-2026 3:54pm EST
$6.10
$0.02
-0.33%
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 226.6M | IPO Year: | 2020 |
| Target Price: | $12.00 | AVG Volume (30 days): | 256.8K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.54 | EPS Growth: | 125.47 |
| 52 Week Low/High: | $3.55 - $9.34 | Next Earning Date: | 03-03-2026 |
| Revenue: | $56,197,000 | Revenue Growth: | -5.76% |
| Revenue Growth (this year): | 19.44% | Revenue Growth (next year): | 18.63% |
| P/E Ratio: | 11.33 | Index: | N/A |
| Free Cash Flow: | -24643000.0 | FCF Growth: | N/A |
AI-Powered MASS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 77.78%
77.78%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of 908 Devices Inc. (MASS)
McCallion Kevin J.
Sell
SVP, Products and Production
MASS Mar 2, 2026
Avg Cost/Share
$7.00
Shares
7
Total Value
$49.00
Owned After
44,918
SEC Form 4
Griffith Joseph H. IV
Sell
Chief Financial Officer
MASS Feb 2, 2026
Avg Cost/Share
$6.18
Shares
23,175
Total Value
$143,221.50
Owned After
139,896
SEC Form 4
Knopp Kevin J.
Sell
President and CEO
MASS Feb 2, 2026
Avg Cost/Share
$6.18
Shares
34,764
Total Value
$214,841.52
Owned After
795,968
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| McCallion Kevin J. | MASS | SVP, Products and Production | Mar 2, 2026 | Sell | $7.00 | 7 | $49.00 | 44,918 | |
| Griffith Joseph H. IV | MASS | Chief Financial Officer | Feb 2, 2026 | Sell | $6.18 | 23,175 | $143,221.50 | 139,896 | |
| Knopp Kevin J. | MASS | President and CEO | Feb 2, 2026 | Sell | $6.18 | 34,764 | $214,841.52 | 795,968 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Mar 3, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYMar 3, 2026 · 100% conf.
AI Prediction BUY
1D
-0.13%
$6.31
Act: +6.65%
5D
+11.94%
$7.07
Act: -1.50%
20D
+22.42%
$7.74
Price: $6.32 Prob +5D: 100% AUC: 1.000
0001104659-26-022548
908 Devices Inc._March 3, 2026 0001555279false00015552792026-03-032026-03-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 3, 2026
908 Devices Inc. (Exact name of registrant as specified in its charter)
Delaware 001-39815 45-4524096
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
44 3rd Avenue, Burlington, MA 01803 (Address of principal executive offices, including zip code) (857) 254-1500 (Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share
MASS
The NASDAQ Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On March 3, 2026, 908 Devices Inc. (“908 Devices”) announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Report on Form 8-K. Additionally, on March 3, 2026, 908 Devices posted an updated investor presentation under the “Events & Presentations” section of the 908 Devices website. The information contained in Item 2.02 of this Current Report on Form 8-K is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits:
Exhibit No. Description
99.1 Press release issued by 908 Devices on March 3, 2026
104 Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 3, 2026 908 Devices Inc.
By: /s/ Mark S. Levine
Name: Mark S. Levine
Title: Chief Legal and Administrative Officer
2025 Q4 Q4 2025 Earnings
8-K BUY Jan 20, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYJan 20, 2026 · 100% conf.
AI Prediction BUY
1D
-0.13%
$6.31
Act: +6.65%
5D
+11.94%
$7.07
Act: -1.50%
20D
+22.42%
$7.74
Price: $6.32 Prob +5D: 100% AUC: 1.000
0001104659-26-004798
908 Devices Inc._January 20, 2026 0001555279false00015552792026-01-202026-01-20
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 20, 2026
908 Devices Inc. (Exact name of registrant as specified in its charter)
Delaware 001-39815 45-4524096
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
44 3rd Avenue, Burlington, MA 01803 (Address of principal executive offices, including zip code) (857) 254-1500 (Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share
MASS
The NASDAQ Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition. On January 20, 2026, 908 Devices Inc. (“908 Devices”) announced its preliminary financial results for the fourth quarter and fiscal year ended December 31, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Report on Form 8-K. The information contained in Item 2.02 of this Current Report on Form 8-K is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits:
Exhibit No. Description
99.1 Press release issued by 908 Devices on January 20, 2026
104 Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 20, 2026 908 Devices Inc.
By: /s/ Mark S. Levine
Name: Mark S. Levine
Title: Chief Legal and Administrative Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 10, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 10, 2025
0001104659-25-108811
false 0001555279
0001555279
2025-11-10 2025-11-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 10, 2025
908 Devices Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-39815
45-4524096
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
44 Third Avenue, Burlington,
MA 01803
(Address of principal executive offices, including zip code)
(857) 254-1500
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share
MASS
The NASDAQ Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02 Results of Operations and Financial Condition.
On November 10, 2025, 908 Devices Inc. (“908 Devices”) announced its financial results for the third quarter ended September 30, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Report on Form 8-K.
The information contained in Item 2.02 of this Current Report on Form 8-K is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
Exhibit
No.
Description
99.1
Press release issued by 908 Devices on November 10, 2025
104
Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 10, 2025 908 Devices Inc.
By: /s/ Michael S. Turner
Name: Michael S. Turner
Title: Chief Legal and Administrative Officer
Latest 908 Devices Inc. News
MASS Breaking Stock News: Dive into MASS Ticker-Specific Updates for Smart Investing
Compare MASS vs Leading Stocks
See how MASS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MASS 908 Devices Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.